|[March 03, 2014]
Pharmaron Earns CFDA GLP Certification for Toxicology Facility
BEIJING --(Business Wire)--
Pharmaron announced today that the company's GLP toxicology facilities
in Beijing have earned a certificate of full GLP compliance from the
Chinese Food and Drug Administration (CFDA) based upon a thorough
inspection of its facilities, operating procedures and technical
competency of the staff. Pharmaron is currently under contract with
Sponsors wishing to file INDs in China as the result of this news.
"This certification by the CFDA is a reflection of Pharmaron's
commitment to fully comply with the CFDA's GLP standards. It provides
another avenue for our Sponsors to submit regulatory data from our
facilities. Pharmaron is well positioned today to provide toxicology and
regulatory expertise to our customers intending to include the China
market in their drug development strategy," commented Pharmaron Chairman
and CEO, Dr. Boliang Lou.
Pharmaron is a premier R&D service provider for the pharmaceutical and
biotech industries. Founded in 2003, Pharmaron invests in its people and
facilities enabling the Company to provide high quality R&D service
across a number of disciplines, including chemistry, biology, DMPK,
pharmacology, safety assessment, chemical and pharmaceutical development.
Pharmaron is steadily growing to meet the needs of its partners. With
more than 2,000 employees and operations in China and the U.S.,
Pharmaron delivers superior scientific services while maintaining close
communication with partners.
Pharmaron's mission is to provide the highest quality drug R&D services,
helping our partners advance their projects in a timely and cost
effective manner. More information is available at www.pharmaron.com.
[ Back To Technology News's Homepage ]